Vanda Pharmaceuticals reported $3.79M in Pre-Tax Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.57M 79M
Agios Pharmaceuticals AGIO:US $ -91.81M 2.97M
Alnylam Pharmaceuticals ALNY:US $ -274.67M 35.32M
Anika Therapeutics ANIK:US $ -3.28M 0.42M
Arrowhead Research ARWR:US $ -72.05M 116.41M
AstraZeneca AZN:LN 258259.83M 36783.7M
Bluebird Bio BLUE:US $ -100.14M 22.01M
Clovis Oncology CLVS:US $ -71.37M 11.08M
Enanta Pharmaceuticals ENTA:US $ -32.15M 1.44M
Esperion Therapeutics ESPR:US $ -66324000 9.59M
Halozyme Therapeutics HALO:US $ 30.01M 51.62M
Insmed INSM:US $ -95144000 908K
Intercept Pharmaceuticals ICPT:US $ -20.32M 3.04M
Lexicon Pharmaceuticals LXRX:US $ -24587000 1.11M
Minerva Neurosciences NERV:US $ -8.72M 1.05M
Novartis NVS:US $ 4129M 217M
Ptc Therapeutics PTCT:US $ -148.7M 26.8M
Sangamo Biosciences SGMO:US $ -43.09M 0.83M
Sanofi SAN:FP € 2660M 305M
Takeda 4502:JP Y 155473M 209520M
Teva Pharmaceutical TEVA:IT -1160000000 189M
Ultragenyx Pharmaceutical RARE:US $ -157.86M 6.1M
Vanda Pharmaceuticals VNDA:US $ 3.79M 11.35M
Veracyte VCYT:US $ -9.65M 4.82M